A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2016; you can also visit the original URL.
The file type is
Key words: rHuEpo; iron status; ferritin; transferrin pathy, one from interstitial nephritis, and one from chronic glomerulonephritis. All patients were treated saturation; hypochromic red blood cells; soluble transferrin receptor; dialysis with i.v. rHuEpo and i.v. iron saccharate for at least 12 months. Iron saccharate ( Ferrivenin, Laevosan, Austria) was given in 10-, 20-or 40-mg doses at the end of each haemodialysis treatment to maintain trans-doi:10.1093/ndt/12.8.1575 pmid:9269632 fatcat:knwo6fyjezei3nu3allqsexpny